Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Infusion Pumps: a structured approach to drug library optimizationDennis M. Killian, Pharm.D., Ph.D.Pharmacy DirectorPeninsula Regional Medical Center
Associate ProfessorUMES School of Pharmacy
AAMI FoundationVision: Healthcare technology promotes positive patient and healthcare provider outcomes and causes no harm
NEW: Annual Meeting – Hot Topics in Healthcare!San Diego, CA—November 18 and 19, 2017- 2 day
conferenceNursing CEs and Respiratory Therapist CEs...great
presentations and great food!$50 dollars/day or $70 dollars for both days
Mark your calendars….registration info and final agenda will be sent to you next week
A Special Thanks
Thank You to Our Premiere Industry PartnersWithout the generous support of our industry partners, we would not be able to produce the many tools and deliverables created by the coalition to help you improve infusion therapy safety. The AAMI Foundation is managing all costs for the series. The seminar does not contain commercial content. PlatinumDiamond Gold
5
Infusion Pumps: a structured approach to drug library optimization
Dennis M. Killian, Pharm.D., Ph.D.
Pharmacy Director
Peninsula Regional Medical Center
Associate Professor
UMES School of Pharmacy
6
Disclosure
• The views and opinions presented are entirely my own. They do not necessarily reflect the views of Peninsula Regional Medical Center or the University of Maryland Eastern Shore School of Pharmacy.
• I have served as a speaker on behalf of Baxter Healthcare in regards to IV infusion devices and how to achieve a high level of drug library compliance.
7
Learning Objectives
• Define Dose Error Reduction System (DERS) and identify key components of this vital smart pump safety software.
• Explain the purpose of Continuous Quality Improvement (CQI) reports and how to leverage this data to optimize smart pump safety features and identify near misses.
• Discuss wireless connectivity for infusion pumps and best demonstrated practices for publishing drug library updates.
• Identify scenarios where Clinical Conditions (Modifiers) can be used to help promote safe IV medication delivery.
8
Peninsula Regional Medical Center
• 3000+ employees; 350+ physicians 21,000 admissions• 289 acute care, 28 nursery beds 95,000 ED visits• 30 pharmacists; 50 pharmacy technicians
www.peninsula.org
9
Peninsula Regional Medical Center
10
Peninsula Regional Medical CenterAutomation Overview
• EPIC Electronic Health Record• Baxter SIGMA Spectrum Infusion System• KitCheck: passive RFID tagging of medications• ICU Medical Diana® oncology dose system• Omnicell MedCarousel: inventory management• Pearson Medical high speed oral unit dose
packagers• Baxter EXACTAMIX 2400 Compounder and
REPEATER Pump• Baxter DoseEdge Pharmacy Workflow Manager• Omnicell AcuDose, Anes-Rx, NarcStation• McKesson Horizon Platform: BCMA, CPOE
20162015
2012
2008
11
12
• Intelligence, is essentially the medication or Drug Library and all the associated safety features with this software.
• We need to use the Drug Library as much as possible to help enhance infusion safety measures.
• Not using the Drug Library is comparable to the scarecrow not using his newfound intelligence.
What is the “Drug Library”?
13
Infusion DevicesMarket Analysis
• KLAS– http://www.klasresearch.com/
– Feedback from healthcare professionals
– “Best in KLAS”
• ECRI– https://www.ecri.org/
– Evidence-based evaluations
13
14
Infusion DevicePRMC Vendor Fair Scoring
14
15
Infusion DevicePRMC Decision Matrix
15
16
Infusion Pump Decision
• Which of the following can be used when deciding on an infusion device:
(select all that apply)
A. Decision Matrix
B. Market Intelligence (e.g., KLAS, ECRI)
C. Opinions from other facilities
D. Vendor Fair
16
17
Infusion Pump Decision
• Which of the following is not a key driver for purchasing an infusion device?
A. Cost
B. Efficiency / Ease of Use
C. Safety Features
D. RTLS (Real-Time Location System) Integration
E. Wireless Integration
17
18
Drug Library orDose Error Reduction System (DERS)
• Defaults to the drug library, not opt-in– Must opt-out of drug library, if needed– Helps to ensure a high level of drug library
compliance
• PRMC Drug Library Specifics:– Care Areas: 30
• ED, ICU, Cath Lab, Oncology etc.
– Medication Entries: 411• All Care Area entries are linked to a master medication listing
18
19
• Lower Hard Limit
• Lower Soft Limit
• Default Starting Rate*
• Upper Soft Limit
• Upper Hard Limit
19
Key Factors for Peninsula Regional
• Clinical Advisories• Default Volume to be
Infused*• Dose Rate/Change
(Titration) limits*• Default Bolus amount
and time*
*Peninsula Regional identifiedthese as key factors for safe IV medication delivery
20
• Ability to default the starting rate and volume to be infused (VTBI) for end users
– Improved standardization
– Removes guessing
20
Key Factors for Peninsula Regional
21 21
Key Factors for Peninsula Regional
22 22
Drug Library SetupLinking Entries
23
Drug Library Setup Question
• When establishing drug library parameters for an intermittent IV antibiotic (e.g., ampicillin), which of the following is the least important from a patient safety standpoint:
A. Default starting rateB. Volume to be infused (VTBI)C. Upper soft limitD. Lower hard limitE. Upper hard limit
23
24
Continuous Quality Improvement (CQI)
Immediately After Implementation
May 2015
24
25
Continuous Quality ImprovementDERS Compliance – May/June 2015
25
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
EP L
abCa
th L
abN
ICU
Peds
ED
4 So
uth
CDU
ICU ED
4 W
est
2 W
est
2 Ea
stEn
do/O
RU/S
DS
5 Ea
st B
PCU
Ane
sthe
sia
3 La
yfie
ld3
Wes
tCT
ICU
5 W
est
5 La
yfie
ldCO
DE
PACU
Dia
lysi
s5
Sout
hPe
dsM
OB
5 Ea
st A
OPI
Radi
olog
y
DERS Mode
% D
ERS
Com
plia
nce
26
Continuous Quality ImprovementDERS Compliance – May/June 2015
26
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
EP L
abCa
th L
abN
ICU
Peds
ED
4 So
uth
CDU
ICU ED
4 W
est
2 W
est
2 Ea
stEn
do/O
RU/S
DS
5 Ea
st B
PCU
Ane
sthe
sia
3 La
yfie
ld3
Wes
tCT
ICU
5 W
est
5 La
yfie
ldCO
DE
PACU
Dia
lysi
s5
Sout
hPe
dsM
OB
5 Ea
st A
OPI
Radi
olog
y
DERS Mode
% D
ERS
Com
plia
nce
27
Continuous Quality ImprovementSoft Limit Alerts
27
0
100
200
300
400
500
600
700
800
900
OPI ED 4 South ICU 3 West
# of
Sof
t Lim
its E
xcee
ded
Top 5 Care Areas Exceeding Soft Limits
28
Continuous Quality ImprovementSoft Limit Alerts
28
0100200300400500600700800900
1000
# of
Sof
t Lim
it Ex
ceed
ed
Top 10 Medications Exceeding Soft Limits
29
Continuous Quality ImprovementHard Limit Alerts
29
0
10
20
30
40
50
60
ED 3 West OPI 5 South 2 West
# of
Har
d Li
mtis
Att
empt
edTop 5 Care Areas Attempting Hard Limits
(Excluding IV fluids)
30
Continuous Quality ImprovementHard Limit Alerts
30
0
10
20
30
40
50
60
70
80
90
# of
Har
d Li
mtis
Att
empt
ed
Top 10 Medications Attempting Hard Limits
31
0
10
20
30
40
50
60
70
80
90
# of
Har
d Li
mtis
Att
empt
ed
Top 10 Medications Attempting Hard Limits
Continuous Quality ImprovementHard Limit Alerts
31
32
Continuous Quality ImprovementAlert Optimization
• Gemba and discuss with key stakeholders– Outpatient infusion area
– ED
– Anesthesia
– Cath/EP Lab
– Labor & Delivery
– Clinical nurse specialists
• Discussion: current practice vs recommended practice
33
Continuous Quality Improvement (CQI)
A Few Months After Implementation
June/July 2015
33
34
Continuous Quality ImprovementDERS Compliance – Before and After
35
Continuous Quality ImprovementSoft/Hard Alerts – Before and After
85.7
12.1
2.2
95.8
2.9 1.30
10
20
30
40
50
60
70
80
90
100
normal soft limit hard limit
Perc
enta
ge
before after
36
Continuous Quality ImprovementSoft/Hard Alerts – Before and After
85.7
12.1
2.2
95.8
2.9 1.30
10
20
30
40
50
60
70
80
90
100
normal soft limit hard limit
Perc
enta
ge
before after
40% Reduction
75% Reduction
37
Continuous Quality Improvement (CQI)
Current State
37
38
Continuous Quality ImprovementDERS Compliance – Our Recent Data
39
Continuous Quality ImprovementDERS Compliance – Feb17
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Peds
2 Ea
stED
-Ped
s4
Sout
h2
Wes
tD
ialy
sis
PACU
5 So
uth
3 Ea
st O
ncol
ogy
3 W
est
ICU
5 W
est
5 Ea
stCT
ICU ED
Endo
/ORU
/SD
S5
Layf
ield
EP L
ab3
Layf
ield
4 W
est
Ane
sthe
sia
PCU
Cath
Lab
MO
BN
ICU
OPI
Radi
olog
yTr
aini
ng U
se O
nly
DER
S Co
mpl
ianc
e (%
)
40
Continuous Quality ImprovementDERS Compliance – Feb17
75.4%
89.3% 92.7% 94.1% 94.9%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Peds 2 East ED-Peds 4 South 2 West
DER
S Co
mpl
ianc
e (%
)
41
Hard/Soft AlertsFeb 2017
• Total program events– 17,474
• Soft alerts– 894 (5%)
• Reprogram: 11%
• Continue: 89%
• Hard alerts– 231 (1.3%)
41
42
Continuous Quality Improvement
• Which of the following is not a positive benefit from interpreting CQI data:
A. Review drug library compliance
B. Obtain user satisfaction
C. Review soft limit overrides
D. Review hard limit attempts
42
43
Infusion DeviceWireless Integration
43
44
Infusion DeviceWireless Integration
44
45
Infusion DeviceWireless Integration
45
Labor Intensive
Extensive Scheduling
Time Demands
Different (outdated) Drug Libraries at the
Bedside
1. Forced to move to semi-annual updates instead of quarterly updates
2. Frustration amongst staff due to change in drug library from pump to pump
3. Higher possibility of patient safety risk
46
Infusion DeviceWireless Integration
• Wireless connectivity is more complex than simply connecting to “WiFi”
• Bi-directional wireless integration is the goal
– Drug library updates
• Data from a central hosted server to the pumps
– CQI data
• Data from pumps to a central hosted server
46
47
Infusion DeviceWireless Integration
• Medication library updates• Can initiate an update to the medication library in a few minutes
• Majority of pumps receive the update in less than 10 minutes
• No end user intervention required for the update to occur
• No pump “down time” required
47
Server 726 Pumps
802.11
48
Infusion DeviceRTLS Integration
• RTLS = real-time locating system
• PRMC uses the Stanley Aeroscout system
• Integration of Stanley w/Baxter Sigma occurred in early 2017
• Sigma has an integrated RTLS tag in its battery module
48
49
Infusion DeviceRTLS Integration
49
50
Clinical Conditions(Modifiers)
• Drug library build team
– Vendor, pharmacists, nurses, physicians
• Post-live = multi-disciplinary team
– P&T committee, CP&S
50
PromptSelect Drug
Drug 1
Drug 2
Drug 3
51
Clinical Conditions(Modifiers)
51
52
Clinical Conditions(Modifiers)
52
53
Clinical Conditions(Modifiers)
53
54
Clinical Conditions(Modifiers)
54
55
Clinical Conditions(Modifiers)
• Which of the following situations could benefit from the use of a clinical condition? (Select all that apply)
A. Vasopressin dosing for two different indicationsB. Propofol dosing for both bolus and infusionC. Multi-step infusion (e.g., IVIG)D. A medication that requires a 0.22-
micron filter
55
56
Continuous Quality ImprovementDERS Compliance – Benchmarking
• Regenstrief Center for Healthcare Engineering– Catalyzecare.org– Purdue University
• Performs benchmarking for compliance data• Data analysis for alerts• Contact: Richard Zink ([email protected])
57
Continuous Quality ImprovementDERS Compliance – Benchmarking
Data from: Regenstrief Center for Healthcare Engineering,Infusion Pump Informatics
58
Continuous Quality ImprovementDERS Compliance – Benchmarking
Data from: Regenstrief Center for Healthcare Engineering,Infusion Pump Informatics
59
Continuous Quality ImprovementDERS Compliance – Benchmarking
Data from: Regenstrief Center for Healthcare Engineering,Infusion Pump Informatics
60
Continuous Quality ImprovementDERS Compliance – Benchmarking
Data from: Regenstrief Center for Healthcare Engineering,Infusion Pump Informatics
61
Infusion Pumps & EMR Integration
• Peninsula Regional has migrated to the EPIC EMR in November 2016.
• Our plan is to integrate our infusion pumps with the new EMR system as part of optimization.
61
62
Conclusions
• Implement a structured approach when deciding on an infusion device.
• Default starting rates, VTBI etc. whenever possible to improve standardization.
• Leverage CQI data in coordination with gemba to optimize DERS compliance and minimize unnecessary soft and hard limit alerts.
62
63
Conclusions
• Leverage wireless connectivity to efficiently publish drug library updates with minimal disruption to end users.
• Use clinical conditions (modifiers) in key situations to improve IV medication safety and streamline user interaction with an IV infusion device.
63
64
References
1. https://catalyzecare.org/remedi (accessed: 15-April-2017)
2. http://www.klasresearch.com/ (accessed: 15-April-2017)
3. http://www.ecri.org (accessed: 15-April-2017)
64
Future/Ongoing Initiatives9/25/2013 65
Upcoming SeminarsMark your calendars for these 3 great learning opportunities!
September 11, 2017 – 12 noon to 1pm ESTSonia Pinkney, PEng, MHSc | Manager, Electromedical Group, Medical Engineering, University Health Network | Human Factors Engineer, HumanEra | Adjunct Lecturer, IHPME, University of Toronto
Making the Invisible VisibleSecondary IV infusions and shared infusion volume
Learn how to address the risks through education, workflow changes and technology
9/25/2013 66
September 18, 2017 – 12 noon to 1pm ESTPeggy Bartholomew, MHSM, RN, PMPProject ManagerQuality Project ManagementUT Southwestern Medical Center
A Journey to Reducing Alarm Fatigue; Tips on What Not to Do
Identify operational barriers to impacting alarm reduction Identify clinician barriers to impacting alarm reduction
Learn recommendations to reduce non-actionable alarms
9/25 67
September 25, 2017 - 12 noon to 1pm ESTSonia Pinkneyand
Andrea Cassano-Piché, M.A.Sc., P.EngHuman Factors Engineering ConsultantHuman Factors North Inc., CanadaWhere’s My Line?
Learn how to reduce the safety risks associated with problems in IV line identification and with IV pump boluses
with validated evidence-based recommendations
9/25/2013 68
Thank You to Our Premiere Industry PartnersWithout the generous support of our industry partners, we would not be able to produce the many tools and deliverables created by the coalition to help you improve infusion therapy safety. The AAMI Foundation is managing all costs for the series. The seminar does not contain commercial content. PlatinumDiamond Gold
Consider Making a Tax Deductible Donation to the AAMI Foundation
Today!
Making Healthcare Technology Safer, Together
Thank you for your support!
http://my.aami.org/store/donation.aspx
Questions?
• Post a question on AAMI Foundation’s LinkedIn• Type your question in the “Question” box on your webinar dashboard• Or you can email your question to: [email protected].
Thank you for attending!
This presentation will be posted to this webpage within one week with a Certificate of Participation:
http://www.aami.org/PatientSafety/content.aspx?ItemNumber=3694&navItemNumber=3089